Medisum Biotech Private Limited

Product Description:

Empazose L-10 is a combination oral anti-diabetic medication containing Empagliflozin and Linagliptin, used for the management of type 2 diabetes mellitus in adults. It is prescribed when blood sugar levels are not adequately controlled with a single medication.

This dual-action therapy works by two complementary mechanisms—Empagliflozin helps eliminate excess glucose through urine, while Linagliptin increases insulin release and decreases glucose production—leading to improved glycemic control.

Key Benefits:

• Dual mechanism for enhanced blood sugar control
• Reduces both fasting and post-meal glucose levels
• Helps in weight management
• Low risk of hypoglycemia when used as directed
• Supports overall metabolic health

Composition:

• Each film-coated tablet contains:
  • Empagliflozin 10 mg
  • Linagliptin 5 mg

Indications:

• Type 2 Diabetes Mellitus (when combination therapy is required)